Beacon Cephalosporin Ltd.,

Beacon Cephalosporin Ltd. is an allopathic pharmaceutical manufacturer registered with the Directorate General of Drug Administration (DGDA) at Kathalia, Bhaluka, Mymensingh. The company is listed with Functional status and an Allopathic licence category.

DGDA registration

• DGDA status: Functional
• Licence category: Allopathic
• Registered address: Kathalia, Bhaluka, Mymensingh

Cephalosporin manufacturing

The company operates as a dedicated manufacturing concern for cephalosporin antibiotics. The facility described in the source was established in Bhaluka on 3 acres of land with an investment of Tk 250 crore and was designed specifically for cephalosporin production.

The facility was planned to produce 20 types of cephalosporins in injection, oral tablet, capsule and dry syrup forms. Its production scope reflects the use of dedicated manufacturing arrangements for antibiotic products.

Facility and quality focus

The Bhaluka facility was established with segregation intended to reduce cross-contamination risks associated with antibiotic manufacturing. The source also describes quality-control work involving approved raw materials, product development and trial production before commercial operations.

The facility includes an effluent treatment plant for managing manufacturing waste. The source also states that Beacon followed World Health Organization guidelines for manufacturing the specific antibiotics, with skilled pharmacists involved in quality assurance.